In a recent paper from the nNGM network in Germany examining MET aberrations in NSCLC, Kron et al. reported four cases with MET ex 14 skipping mutations in stage IIIB/IV SCC, further arguing in favor of testing all NSCLC cases, irrespective of histological subtype [26]. The gene discussed is MET; the disease is non-small cell lung carcinoma.